Marie Landel and Maya Said Nominated to be Independent Members of Transgene’s Board of Directors

information fournie par Boursorama •19/04/2017 à 18:00

Strasbourg, France, April 19, 2017, 6:00 p.m. CET - Transgene (Euronext Paris: TNG), a company that designs and develops viral-based immunotherapies, today announced the evolution and reinforcement of the Company’s Board of Directors. In the Annual General Meeting notice published today, Transgene’s Board of Directors has proposed a resolution to shareholders to appoint two new independent board members, Marie Landel and Maya Said. The notice also proposes resolutions on the renewal of the mandates of current Board members Philippe Archinard, Benoît Habert, Alain Mérieux, Dominique Takizawa (representing TSGH). Following the Shareholders General meeting on June 8, 2017, assuming shareholder approval of these proposals, Transgene’s Board of Directors will comprise ten members, with a majority of independent members.